Rufinamide

Details

Files

Generic Name:

Rufinamide

Project Status:

Complete

Therapeutic Area:

Lennox-Gastaut syndrome

Manufacturer:

Eisai Limited

Call for patient/clinician input open:

September 7, 2011

Brand Name:

Banzel

Project Line:

Reimbursement Review

Project Number:

SR0252-000

Call for patient/clinician input closed:

October 13, 2011

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Lennox-Gastaut syndrome; adjunctive treatment of seizures

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

March 15, 2012

Last Updated : September 20, 2011